Clinical heterogeneity in lymphoedema-distichiasis with FOXC2 truncating mutations
- PMID: 11694548
- PMCID: PMC1734771
- DOI: 10.1136/jmg.38.11.761
Clinical heterogeneity in lymphoedema-distichiasis with FOXC2 truncating mutations
Abstract
Background: Hereditary lymphoedema-distichiasis (LD) is an autosomal dominant disorder that classically presents as lymphoedema of the limbs, with variable age of onset, and extra aberrant growth of eyelashes from the Meibomian gland (distichiasis). Other major reported complications include cardiac defects, cleft palate, and extradural cysts. Photophobia, exotropia, ptosis, congenital ectropion, and congenital cataracts are additional eye findings. Recently, we reported that truncating mutations in the forkhead transcription family member FOXC2 resulted in LD in two families.
Methods: The clinical findings in seven additional families with LD, including the original family described by Falls and Kertesz, were determined and mutational analyses were performed.
Results: Distichiasis was the most common clinical feature followed by age dependent lymphoedema. There is a wide variation of associated secondary features including tetralogy of Fallot and cleft palate. The mutational analyses identified truncating mutations in all of the families studied (two nonsense, one deletion, three insertion, and one insertion-deletion), which most likely result in haploinsufficiency of FOXC2.
Conclusions: FOXC2 mutations are highly penetrant with variable expressivity which is not explicable by the pattern of mutations.
Similar articles
-
Analysis of the phenotypic abnormalities in lymphoedema-distichiasis syndrome in 74 patients with FOXC2 mutations or linkage to 16q24.J Med Genet. 2002 Jul;39(7):478-83. doi: 10.1136/jmg.39.7.478. J Med Genet. 2002. PMID: 12114478 Free PMC article.
-
Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome.Am J Hum Genet. 2000 Dec;67(6):1382-8. doi: 10.1086/316915. Epub 2000 Nov 8. Am J Hum Genet. 2000. PMID: 11078474 Free PMC article.
-
FOXC2 truncating mutation in distichiasis, lymphedema, and cleft palate.Clin Genet. 2002 Dec;62(6):470-3. doi: 10.1034/j.1399-0004.2002.620608.x. Clin Genet. 2002. PMID: 12485195
-
Novel FOXC2 missense mutation identified in patient with lymphedema-distichiasis syndrome and review.Lymphology. 2008 Sep;41(3):98-102. Lymphology. 2008. PMID: 19013876 Review.
-
Phenotypic characterization of primary lymphedema.Ann N Y Acad Sci. 2008;1131:140-6. doi: 10.1196/annals.1413.013. Ann N Y Acad Sci. 2008. PMID: 18519967 Review.
Cited by
-
Foxc2 is essential for podocyte function.Physiol Rep. 2019 May;7(9):e14083. doi: 10.14814/phy2.14083. Physiol Rep. 2019. PMID: 31062503 Free PMC article.
-
Dysmorphogenesis of lymph nodes in Foxc2 haploinsufficient mice.Histochem Cell Biol. 2011 Jun;135(6):603-13. doi: 10.1007/s00418-011-0819-x. Epub 2011 May 26. Histochem Cell Biol. 2011. PMID: 21614587
-
Meibomian Gland Disease: The Role of Gland Dysfunction in Dry Eye Disease.Ophthalmology. 2017 Nov;124(11S):S20-S26. doi: 10.1016/j.ophtha.2017.05.031. Ophthalmology. 2017. PMID: 29055358 Free PMC article. Review.
-
Cancer and lymphatic marker FOXC2 drives wound healing and fibrotic tissue formation.Front Physiol. 2024 Oct 15;15:1427113. doi: 10.3389/fphys.2024.1427113. eCollection 2024. Front Physiol. 2024. PMID: 39473610 Free PMC article.
-
Analysis of the phenotypic abnormalities in lymphoedema-distichiasis syndrome in 74 patients with FOXC2 mutations or linkage to 16q24.J Med Genet. 2002 Jul;39(7):478-83. doi: 10.1136/jmg.39.7.478. J Med Genet. 2002. PMID: 12114478 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
- P60 DE013076-01S10005/DE/NIDCR NIH HHS/United States
- R01 DE014667/DE/NIDCR NIH HHS/United States
- R01 DE014667-02/DE/NIDCR NIH HHS/United States
- P60 DE013076-03S10005/DE/NIDCR NIH HHS/United States
- 1P60DE13086-01/DE/NIDCR NIH HHS/United States
- R01 DE014667-03/DE/NIDCR NIH HHS/United States
- P60 DE013076-030005/DE/NIDCR NIH HHS/United States
- P60 DE013076-050005/DE/NIDCR NIH HHS/United States
- P60 DE013076-010005/DE/NIDCR NIH HHS/United States
- P60 DE013076-020005/DE/NIDCR NIH HHS/United States
- P60 DE013076-040005/DE/NIDCR NIH HHS/United States
- R01 DE014667-04/DE/NIDCR NIH HHS/United States
- P60 DE013076/DE/NIDCR NIH HHS/United States
- R01 DE014667-01/DE/NIDCR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials